1 mg retatrutide VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide Peptide | Research Peptide

Their main side effects are usually nausea and vomiting. In TRIUMPH-2, up to 11.6 percent of participants using retatrutide stopped the drug before the end of the trial due to side effects, compared with 4.9 percent of the placebo group

Understanding retatrutide Retatrutide, also known as LY3437943, is a drug that simultaneously activates the receptors for three hormones: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon (GCG)

For a person targeting 160 pounds, that means 96 to 120 grams of protein daily

Medications like Ozempic, Zepbound, Wegovy and Mounjaro aren't cheap

Sitagliptin blocks DPP-4, an enzyme that breaks down incretin hormones